Cingulate Inc. Files Q1 2025 10-Q Report
Ticker: CINGW · Form: 10-Q · Filed: May 8, 2025 · CIK: 1862150
| Field | Detail |
|---|---|
| Company | Cingulate Inc. (CINGW) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Cingulate Inc. 10-Q filed. Q1 2025 financials out.
AI Summary
Cingulate Inc. filed its quarterly report for the period ending March 31, 2025. The company, operating in the pharmaceutical preparations sector, is based in Kansas City, KS. Key financial data and stock information are detailed within the filing.
Why It Matters
This filing provides investors with an update on Cingulate Inc.'s financial performance and operational status for the first quarter of 2025, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Cingulate Inc. faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the fiscal quarter covered by the report.)
- 2025-05-08 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
Key Players & Entities
- Cingulate Inc. (company) — Filer of the 10-Q report
- 20250331 (date) — End of the reporting period
- 20250508 (date) — Date of filing
- Kansas City, KS (location) — Company's business and mail address
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the primary business of Cingulate Inc.?
Cingulate Inc. operates in the Pharmaceutical Preparations sector, as indicated by its SIC code 2834.
For which fiscal period is this 10-Q report filed?
This 10-Q report is filed for the period ending March 31, 2025.
Where is Cingulate Inc. headquartered?
Cingulate Inc.'s business and mail address is located at 1901 W. 47th Place, Kansas City, KS 66205.
What is the Central Index Key (CIK) for Cingulate Inc.?
The Central Index Key for Cingulate Inc. is 0001862150.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted to the SEC on May 8, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Cingulate Inc. (CINGW).